Huntington's Disease Trial, Recruiting NCT06546488 Sponsor: Ohio State University Condition: Huntington's Disease
Back to Huntingtons Disease

Huntington's Disease Trial, Recruiting

NCT06546488
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 30 and 65 years old (inclusive) at the time of signing the consent form
  • You have a genetic confirmation of Huntington's disease, shown by a specific gene marker (CAG repeat of 40 or more)
  • You have a confirmed clinical diagnosis of Huntington's disease, verified by a standard diagnostic assessment (confirm with trial site)
  • You have adequate vision and hearing to complete the study tests
  • You have been on the same medication doses for at least 30 days before signing the consent form

Who may not be able to join:

  • Your Huntington's disease symptoms first appeared before age 19 or after age 60
  • You have another serious brain or neurological condition (such as Alzheimer's disease, Parkinson's disease, dementia, ALS, or a history of significant brain injury) that the doctor considers clinically important
  • You have another serious ongoing medical condition, such as an autoimmune disease, active cancer treatment, serious heart failure, severe lung disease, or any history of seizures (including taking anti-seizure medication)
  • You are currently pregnant or breastfeeding
  • You have a history of a learning disability
  • You are unable to provide your own consent to participate in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 6143668642

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ohio State University
Registry
ClinicalTrials.gov
Start date
20 June 2025
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Symbol Digit Modality Test (SDMT) compared to the Coding Test; Self-Administered Gerocognitive Examination (SAGE) score compared to the Symbol Digit Modality Test (SDMT) and the Stroop Word reading scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov